Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,741 to 1,760 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Artificial Tissue Homeostasis Circuit Designed via Analog Circuit Techniques. | IEEE Trans Biomed Circuits Syst | 2019 | 30908238 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. | Environ Res | 2019 | 30903817 | PubTator, text mining | PubMed |
| Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion. | J Proteome Res | 2019 | 30901224 | PubTator, text mining | PubMed |
| Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2019 | 30883650 | PubTator, text mining | PubMed |
| Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells. | Cells | 2019 | 30871063 | PubTator, text mining | PubMed |
Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism. | Front Neurol | 2019 | 30853934 | PubTator, text mining | PubMed |
| Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. | Toxicol In Vitro | 2019 | 30851411 | PubTator, text mining | PubMed |
| Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation. | Indian J Pediatr | 2019 | 30848473 | PubTator, text mining | PubMed |
| A combination of oral L-citrulline and L-arginine improved 10-min full-power cycling test performance in male collegiate soccer players: a randomized crossover trial. | Eur J Appl Physiol | 2019 | 30847640 | PubTator, text mining | PubMed |
| Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. | Ann Neurol | 2019 | 30840313 | PubTator, text mining | PubMed |
| Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer. | Investig Clin Urol | 2019 | 30838341 | PubTator, text mining | PubMed |
| Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. | Cancer | 2019 | 30835824 | PubTator, text mining | PubMed |
| Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment. | Genes (Basel) | 2019 | 30832275 | PubTator, text mining | PubMed |
| Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus. | Sci Rep | 2019 | 30816183 | PubTator, text mining | PubMed |
| Genetics and genomic medicine in Iran. | Mol Genet Genomic Med | 2019 | 30816028 | PubTator, text mining | PubMed |
| LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway. | Theranostics | 2019 | 30809309 | PubTator, text mining | PubMed |
| Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma. | Oncogenesis | 2019 | 30808864 | PubTator, text mining | PubMed |
| Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC. | Mol Cancer Res | 2019 | 30808730 | PubTator, text mining | PubMed |
| Ionizing radiation affects the composition of the proteome of extracellular vesicles released by head-and-neck cancer cells in vitro. | J Radiat Res | 2019 | 30805606 | PubTator, text mining | PubMed |
| Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. | Adv Drug Deliv Rev | 2019 | 30797953 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=88